Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection
What the buyer wrote
Public Health England (PHE) has awarded a contract for the provision of H1V-1 LAg-Avidity ElA kits to Sedia Biosciences Corporation, which is used to monitor recent HIV infection in people in newly diagnosed with HIV as part of national Surveillances. To ensure comparability of data, the same assay is required over time to minimise any variation between assays performance. Sedia LAg assays are used to monitor recent infections in the UK. Sedia Biosciences Corporation is the only manufacturer of the Sedia LAg assay. Alternative LAg assays have been shown to have different performance characteristics following evaluation. Sufficient data have been generated on the Sedia LAg assay to confir…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Work starts
- 20 Sep 2018
- Work ends
- 21 Sep 2019
- Kind of work
- Health and social care, Research, evaluation and insight
Who the buyer named
Richard Blake was the named contact on this notice.